References
- ArmitageJOWeisenburgerDDNew approach to classifying non-Hodgkin’s lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin’s lymphoma classification projectJ Clin Oncol1998168278027959704731
- NguyenTParkerRHawkinsESynergistic interactions between PLK1 and HDAC inhibitors in non-Hodgkin’s lymphoma cells occur in vitro and in vivo and proceed through multiple mechanismsOncotarget2017819314783149328416758
- LaubachJPSan-MiguelJFHungriaVDeacetylase inhibitors: an advance in myeloma therapy?Expert Rev Hematol201710322923728076695
- LeeYSLimKHGuoXThe cytoplasmic deacetylase HDAC6 is required for efficient oncogenic tumorigenesisCancer Res200868187561756918794144
- ZhangZYamashitaHToyamaTHDAC6 expression is correlated with better survival in breast cancerClin Cancer Res200410206962696815501975
- CaiYCuiWChenWThe effects of a histone deacetylase inhibitor on biological behavior of diffuse large B-cell lymphoma cell lines and insights into the underlying mechanismsCancer Cell Int20131315723758695
- GaoHGongZBeyond international prognostic index: risk stratification in diffuse large B-cell lymphomaTransl Cancer Res20176S210S216
- SternerDEBergerSLAcetylation of histones and transcription-related factorsMicrobiol Mol Biol Rev200064243545910839822
- GlozakMASetoEHistone deacetylases and cancerOncogene200726375420543217694083
- GianniniGCabriWFattorussoCRodriquezMHistone deacetylase inhibitors in the treatment of cancer: overview and perspectivesFuture Med Chem20124111439146022857533
- FengWZhangBCaiDZouXTherapeutic potential of histone deacetylase inhibitors in pancreatic cancerCancer Lett2014347218319024534202
- TasoulasJGiaginisCPatsourisEManolisETheocharisSHistone deacetylase inhibitors in oral squamous cell carcinoma treatmentExpert Opin Investig Drugs20152416978
- ChengTGrasseLShahJChandraJPanobinostat, a pan-histone deacetylase inhibitor: rationale for and application to treatment of multiple myelomaDrugs Today201551849150426380387
- GrozingerCMHassigCASchreiberSLThree proteins define a class of human histone deacetylases related to yeast Hda1pProc Natl Acad Sci U S A19999694868487310220385
- VerdelAKhochbinSIdentification of a new family of higher eukaryotic histone deacetylases. Coordinate expression of differentiation-dependent chromatin modifiersJ Biol Chem19992744244024459891014
- SeidelCSchnekenburgerMDicatoMDiederichMHistone deacetylase 6 in health and diseaseEpigenomics20157110311825687470
- LiYShinDKwonSHHistone deacetylase 6 plays a role as a distinct regulator of diverse cellular processesFEBS J2013280377579323181831
- SakumaTUzawaKOndaTAberrant expression of histone deacetylase 6 in oral squamous cell carcinomaInt J Oncol200629111712416773191
- MedlerTRCraigJMFiorilloAAFeeneyYBHarrellJCClevengerCVHDAC6 deacetylates HMGN2 to regulate Stat5a activity and breast cancer growthMol Cancer Res20161410994100827358110
- RamakrishnanSKuSCiamporceroEHDAC 1 and 6 modulate cell invasion and migration in clear cell renal cell carcinomaBMC Cancer20161661727506904
- HideshimaTBradnerJEWongJSmall-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myelomaProc Natl Acad Sci U S A2005102248567857215937109
- SeoJMinSKParkHRExpression of histone deacetylases HDAC1, HDAC2, HDAC3, and HDAC6 in invasive ductal carcinomas of the breastJ Breast Cancer201417432333125548579
- BatchuSNBrijmohanASAdvaniAThe therapeutic hope for HDAC6 inhibitors in malignancy and chronic diseaseClin Sci201613012987100327154743
- DuvicMTalpurRNiXPhase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)Blood20071091313916960145
- OlsenEAKimYHKuzelTMPhase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphomaJ Clin Oncol200725213109311517577020
- MarquardLGjerdrumLMChristensenIJJensenPBSehestedMRalfkiaerEPrognostic significance of the therapeutic targets histone deacetylase 1, 2, 6 and acetylated histone H4 in cutaneous T-cell lymphomaHistopathology200853326727718671804
- MarquardLPoulsenCBGjerdrumLMHistone deacetylase 1, 2, 6 and acetylated histone H4 in B- and T-cell lymphomasHistopathology200954668869819438744
- LeGSMilpiedNJLamyTFirst-line rituximab (R) high-dose therapy (R-HDT) versus R-CHOP14 for young adults with diffuse large B-cell lymphoma: preliminary results of the GOELAMS 075 prospective multicenter randomized trialJ Clin Oncol2011298003